Y-Intercept (HK)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Y-Intercept (HK)’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-49,546	Closed	-$480K	–	988
2021 Q2	$480K	Buy	+49,546	New	+$395K	0.12%	274

Other funds holding SRNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Y-Intercept (HK)'s SRNE Position: Q3 2021 in Review

Y-Intercept (HK) sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2021, closing a stake of 49,546 shares — an estimated $480K sold.

Y-Intercept (HK) first reported a position in SRNE in Q2 2021 and held it in 1 quarter. The position peaked at $480K in Q2 2021. 220 funds tracked by Wall St. Rank hold SRNE as of Q3 2021.

Y-Intercept (HK) reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
Y-Intercept (HK) sold 49,546 Sorrento Therapeutics, Inc. shares in Q3 2021, an estimated $480K.
Y-Intercept (HK) first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 1 quarter.
Y-Intercept (HK)'s Sorrento Therapeutics, Inc. position peaked at $480K in Q2 2021.
220 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2021.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.